Tirzepatide can now be prescribed for weight loss
Previously approved for diabetes treatment, tirzepatide now has the FDA’s approval for weight loss. Now known as Zepbound, the latest anti-obesity medication is the latest tool in doctors’ armamentarium.
Read more at Politico (subscription required)